FOCiS 2018 Day 1: Cancer Vaccine Correlates Revealed through Single-Cell Function

On Day 1 of the FOCiS 2018 Annual Meeting, IsoPlexis presented “Single-cell Highly Multiplexed Proteomics Identifies Novel Polyfunctional Human CD8+ T Cell Signatures Induced by a Nanoparticle-Based Melanoma Vaccine in Human Immune System Mice”. The presented data demonstrates: (1) Nanoparticle-based melanoma vaccine demonstrates capability to induce potent antigen specific human CD8+ T cell response in HIS mice; (2) IsoPlexis’ novel single-cell heatmap and PAT PCA visualizations reveal distinct polyfunctional cell profiles with these combinations human cytokine secretions that drive human CD8+ T cell response by NP vaccine in HIS mice. This IsoPlexis’ platform further dissects the full spectrum of immune cell function and more accurately assesses human CD8+ T cells induced by NP vaccine in HIS mice; (3) The polyfunctional human CD8+ T cell responses sensitively demonstrates successful induction of tumor vaccine, which may enhance accurate evaluation of tumor vaccine efficacy in pre-clinical setting. FOCiS is a leading conference in translational immunology where clinicians and researchers deliver the latest breakthroughs across immune-mediated diseases.

Share This Article
Be in the Know.
Subscribe to the IsoPlexis Blog
Join 10,000+ top scientists and receive industry pioneers' backed data straight to your inbox.
Your data is in safe hands! We'll never share or sell your data to any third parties, and you may unsubscribe at any time.